Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa.

Mercedes Delgado-Valverde Inés Portillo-Calderón Manuel Alcalde-Rico M Carmen Conejo Carmen HidalgoCarlos Del Toro EsperónAlvaro Pascual

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)

Imipenem/relebactam showed excellent activity against K. pneumoniae KPC-3. The activity of imipenem/relebactam against imipenem-resistant P. aeruginosa was moderate.

Keyphrases

klebsiella pneumoniae
multidrug resistant
pseudomonas aeruginosa
escherichia coli
acinetobacter baumannii
drug resistant
biofilm formation